F&O in the press – Unilever bids £50bn for GSK assets




Today’s Proactive Investors website reports on Unilever’s £50bn bid for GlaxoSmithKline’s consumer healthcare business. Unilever reportedly made three unsolicited approaches for the business.

The offer fails to include a significant premium, often required to convince firms to part with their assets. GlaxoSmithKline said the bids fundamentally undervalue the business.

“GSK is thought to be holding out for £60bn”
Marc Kimsey, Frederick & Oliver

Shares in Unilever are currently 5.8% lower, whilst GSK is trading higher by 5.3%. Traders are monitoring the situation in anticipation of an improved offer.

Read the full story here

Sign up to ‘City View’ our award-winning newsletter
Make sure you receive the need-to-know stock market news, every morning. Sign up below.

By Marc Kimsey

Sign Up to City View

To access the latest and most relevant market headlines for your portfolio, sign up to City View here.

Complete the form below to access City View:

Related Blog Posts